Dr. Zackery Logan Gene Fowler, DO Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Glen H. Bailey, D.O. Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Christopher Allen Smith, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-5340 |
Robin M. Mantooth, M.D. Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Aaron Fry, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Robert R. Frantz Jr., M.D. Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Terry J. Hill, D.O. Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Hannah Kramer, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Mark C Sauerwald, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-250-8416 Fax: 405-307-2135 |
Dr. Philip Dzambo, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Dr. Andrew Phillips, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave Ofc, Norman, OK 73071 Phone: 405-307-5340 |
Dr. Casey Ray Liston, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Kurt R. Feighner, D.O. Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Dr. Kimberly Mai, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Thomas E. Ingmire, M.D. Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Dr. Danielle Scheafer, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1500 |
Kevin C. Hoos, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Dr. Esther Elizabeth Walker, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3500 Healthplex Pkwy, Suite #102, Norman, OK 73072 Phone: 405-307-6918 Fax: 405-307-6957 |
Junaid Haroon Riaz, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
Jason K. Benn, D.O. Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 |
News Archive
Researchers at The University of Texas Health Science Center at Houston School of Dentistry and McGovern Medical School have discovered a previously unknown characteristic of brain-cell aging that could help detect late-onset Alzheimer's disease decades before symptoms begin.
UNICEF and its partners "have stepped up vaccination campaigns in Syria, Jordan, Lebanon, Iraq and Turkey amid measles outbreaks in a region already struggling to provide humanitarian assistance to millions of people affected by ongoing conflict in Syria," the U.N. News Centre reports (4/30).
A new blood test which has been developed by scientists in California may enable doctors to predict just who is likely to develop the the degenerative brain disease Alzheimer's.
BioCryst Pharmaceuticals, Inc. announced preliminary top-line results from its multinational, open-label, single-arm trial evaluating 200 mg once-daily oral forodesine in the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL), as well as interim results from the Company's exploratory Phase 2 study to investigate the efficacy and safety of 200 mg twice-daily oral forodesine as monotherapy for chronic lymphocytic leukemia (CLL).
› Verified 3 days ago